Immature platelet values indicate impaired megakaryopoietic activity in neonatal early-onset thrombocytopenia.

Authors:

Malte Cremer Andreas Weimann Gerd Schmalisch Hannes Hammer Christoph Bührer Christof Dame

Thromb Haemost 2010 May 9;103(5):1016-21. Epub 2010 Mar 9.

Department of Neonatology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, D-10117 Berlin, Germany.

Newly released platelets, referred to as immature platelets, can be reliably quantified based on their RNA content by flow cytometry in an automated blood analyser. The absolute number of immature platelets (IPF#) and the immature platelet fraction (IPF%) reflect megakaryopoietic activity. We aimed to analyse the implication of these parameters in analysing the pathomechanism of early-onset neonatal thrombocytopenia. Platelet counts and IPF were determined at day 1 to 3 (d1 to d3) in 857 neonates admitted to intensive care. In thrombocytopenic patients (platelet counts<150 x 10(9)/l, n=129), IPF# was significantly lower (8.5 +/- 2.7 x 10(9)/l), than in non-thrombocytopenic neonates (9.5 +/- 3.6 x 10(9)/l, n=682, p<0.05). IPF% was significantly higher in thrombocytopenic (9.3 +/- 7.9%) vs. non-thrombocytopenic neonates (4.1 +/- 1.8%, p<0.001). While neonates with early-onset infection (n=134) had lower platelet counts (199 +/- 75 x 10(9)/l) compared to controls (230 +/- 68 x 10(9)/l, n=574, p<0.01), there were no differences in IPF# or IPF%. Likewise, "small for gestational age" infants (SGA, n=149) had lower platelet counts at d1 (199 +/- 75 x 10(9)/l, p<0.001) than controls, but no differences in IPF. A trend towards lower IPF# was detected if SGA infants with platelet counts <100 x 10(9)/l (5.4 +/- 3.9 x 10(9)/l, n=11) and thrombocytopenic neonates with infection (9.9 +/- 7.3 x 10(9)/l, n=10, p=0.11) were compared. The evaluation of IPF# indicates that thrombocytopenia in neonates is likely due to a combination of increased platelet consumption and inadequate megakaryopoietic response by the neonatal bone marrow. Furthermore, SGA neonates with moderate and severe thrombocytopenia might have a pronounced suppression of megakaryopoiesis compared to neonates with infection.

Download full-text PDF	Source
http://dx.doi.org/10.1160/TH09-03-0148	DOI Listing

May 2010

Publication Analysis

Similar Publications

Pretreatment Immature Platelet Fraction as a Surrogate of Reticulated Platelets Predicts the Response to Corticosteroids in Adults with Immune Thrombocytopenia.

Authors:

Akiyoshi Takami Shohei Mizuno Ayano Nakamura Jo Kanasugi Hidesuke Yamamoto Lam Vu Quang Yuya Nakagami Yuta Nakano Saki Yamada Saori Matsumura Souichi Takasugi Kaori Uchino Tomohiro Horio Satsuki Murakami Yuka Oohigashi Takayuki Nakayama Hiroya Tani Megumi Enomoto Ichiro Hanamura

Acta Haematol 2020 Sep 17:1-5. Epub 2020 Sep 17.

Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Japan.

Objectives: Reticulated platelets circulating in the blood reflect megakaryopoietic activity and platelet turnover and can be automatically and low-invasively measured as the immature platelet fraction (IPF) using a Sysmex XN hematocytometer. The present study retrospectively investigated whether or not the IPF can predict the treatment response to corticosteroids in adult patients with primary immune thrombocytopenia (ITP).

Methods: Forty-six patients who had been newly diagnosed with primary treatment-naïve ITP and started treatment with corticosteroids were analyzed. Read More

View Article and Full-Text PDF

September 2020

Similar Publications

Identification of the Regulatory Elements and Target Genes of Megakaryopoietic Transcription Factor MEF2C.

Authors:

Xianguo Kong Lin Ma Edward Chen Chad A Shaw Leonard C Edelstein

Thromb Haemost 2019 May 7;119(5):716-725. Epub 2019 Feb 7.

Department of Medicine, Cardeza Foundation for Hematologic Research, Sidney Kimmel Medical School at Thomas Jefferson University, Philadelphia, Pennsylvania, United States.

Megakaryopoiesis produces specialized haematopoietic stem cells in the bone marrow that give rise to megakaryocytes which ultimately produce platelets. Defects in megakaryopoiesis can result in altered platelet counts and physiology, leading to dysfunctional haemostasis and thrombosis. Additionally, dysregulated megakaryopoiesis is also associated with myeloid pathologies. Read More

View Article and Full-Text PDF

May 2019

Similar Publications

Diagnostic value of platelet indices and bone marrow megakaryocytic parameters in immune thrombocytopenic purpura.

Authors:

Yue-Ting Tang Ping He Ya-Zhen Li Huan-Zhu Chen Xiao-Lan Chang Qing-Dong Xie Xiao-Yang Jiao

Blood Coagul Fibrinolysis 2017 Jan;28(1):83-90

aLaboratory Medicine Center, Nangfang Hospital, Southern Medical University, Guangzhou bDepartment of Cell Biology and Genetics, Shantou University Medical College cShantou University Medical College, Shantou, Guangdong, China.

Platelet indices could mirror megakaryopoietic activity in immune thrombocytopenic purpura (ITP), but its specificity and sensitivity need to be studied. The diagnostic performance of platelet indices was analyzed by receiver-operating characteristic curves, and the probability of true positive (sensitivity) and true negative (specificity) in predicting ITP, myelodysplasia, or controls was determined. Mean platelet volume (MPV) was higher, whereas plateletcrit (PCT) was significantly lower in ITP than in myelodysplasia and controls. Read More

View Article and Full-Text PDF

January 2017

Similar Publications

Reference intervals for mean platelet volume and immature platelet fraction determined on a sysmex XE5000 hematology analyzer.

Authors:

Mikala Klok Joergensen Lise Bathum

Scand J Clin Lab Invest 2016 6;76(2):172-6. Epub 2016 Feb 6.

a Department of Clinical Biochemistry , Slagelse-Naestved Hospital , Slagelse , Denmark ;

Background: New parameters describing the platelet population of the blood are mean platelet volume (MPV), which is a crude estimate of thrombocyte reactivity, and immature platelet fraction (IPF), which reflects megakaryopoietic activity. This study aimed to define reference intervals for MPV and IPF and to investigate whether separate reference intervals according to smoking status, age or sex are necessary.

Methods: Blood samples were obtained from subjects participating in The Danish General Suburban Population Study. Read More

View Article and Full-Text PDF

November 2016

Similar Publications

The gene expression signature of anagrelide provides an insight into its mechanism of action and uncovers new regulators of megakaryopoiesis.

Authors:

M Ahluwalia L Butcher H Donovan C Killick-Cole P M Jones J D Erusalimsky

J Thromb Haemost 2015 Jun 9;13(6):1103-12. Epub 2015 May 9.

School of Health Sciences, Cardiff Metropolitan University, Cardiff, UK.

Background: Anagrelide is a cytoreductive agent used to lower platelet counts in essential thrombocythemia. Although the drug has been known to selectively inhibit megakaryopoiesis for many years, the molecular mechanism accounting for this activity is still unclear.

Objectives And Methods: To address this issue we have compared the global gene expression profiles of human hematopoietic cells treated ex-vivo with and without anagrelide while growing under megakaryocyte differentiation conditions, using high-density oligonucleotide microarrays. Read More

View Article and Full-Text PDF

June 2015

Similar Publications

Search Our Scientific Publications & Authors